Hospitals can’t charge patients with advanced cancer treatments the amount of money they would have been able to pay under the new regulations, according to a study released Monday.

Hospitals also can’t deduct a portion of the treatment bill from patients’ insurance premiums, which would be a significant financial blow for patients who rely on the expensive drugs they take.

The study, which was conducted by the National Cancer Institute and the Department of Health and Human Services, found that hospitals that do not charge for radiation, chemotherapy or other therapies for patients without advanced cancer could lose millions of dollars in revenue.

The analysis is based on an analysis of the Medicare and Medicaid programs and estimates that the cost of treatment for patients diagnosed with advanced cancers could drop by $100 million a year.

The Medicare program covers the costs of cancer treatment for Medicare beneficiaries, who are mostly people 65 and older.

It covers about $1.4 trillion in annual spending.

It pays for most cancer treatments, including radiation, surgery, chemotherapy and other treatments.

The program covers more than 40 million people and covers about half of Medicare beneficiaries.

The Medicaid program covers people under age 65 and low-income seniors.

It typically pays for about 30 percent of cancer costs, but the National Institutes of Health estimates that under the Trump administration, that could drop to 25 percent.

The researchers used data from the Medicare program to calculate how much hospitals and medical providers would have to pay for treatment under the proposed rules.

That would include costs of radiation, the cost to treat cancer with chemotherapy, and the cost for chemotherapy and radiation treatment.

The report said that under current law, hospitals could charge patients as much as $2,500 a month, but under the proposal they would be able to deduct a maximum of $1,500.

That deduction could be capped at $1 million.

Hospitals could also charge the $2.5 billion Medicare payment for cancer patients who are enrolled in Medicare Advantage plans, which typically include lower deductibles.

The proposed rules would allow hospitals to charge that money as well.

The study did not estimate how many Medicare beneficiaries would be affected by the proposed change.

“The proposed rules could significantly impact Medicare Advantage patients in terms of the amount they would need to pay,” said the report, which is titled “Hospice and Palliative Care Costs for Medicare Beneficiaries.”

The study is part of a larger effort by the institute to explore the impact of the new Medicare rules on health care spending.

The report was published just days after the House of Representatives approved legislation that would require hospitals to provide radiation therapy to cancer patients.

The Senate has yet to vote on the legislation.